The present invention relates generally to devices for the injection of medicaments and more precisely relates to a device for the automatic injection of medicaments especially a medicament for allergic emergencies, such as epinephrine or adrenaline, according to a requested time sequence. In particular, the invention refers to a device for the automatic injection of two doses of a medicament at two successive times.
Many devices of the above mentioned type allowing a patient to self-administer one or more (generally two) doses of a medicament are known. U.S. Pat. No. 6,575,939 discloses an autoinjector device comprising a syringe housed in a casing formed by an inner part and an outer part capable of sliding in relation to each other. By pressing the end of the inner part (the needle outlet end) against the patient's skin at the injection site, the outer part slides forward along the inner part, thus unlocking a push-button. By depressing the button, the syringe and the relevant plunger are triggered to first thrust in the needle and then deliver the medicament. The needle retraction in the casing is obtained by stopping pressing the outer part end against the skin. This auto-injector allows a single dose of medicament to be administered.
An autoinjector device for automatic administering a single dose of a medicament is also known from U.S. Pat. No. 4,031,893. The autoinjector is equipped with an unlocking device with a deformable member for the driving device. The syringe plunger is axially connected to a rod comprising four flexible axial arms having a toothed end engaged on the edge of an opening formed on a cap placed at the end of the syringe housing. Cap sliding causes the arm ends to deform and their teeth to release from the opening edge. In this way the driving device is triggered. The autoinjector according to this document also comprises a safety device to prevent accidental deformation of the arm ends and triggering of the driving device, consisting of an insert centrally extending from the cap and capable of coming between the rod arms to prevent them from bending.
EP700307 discloses a two-dose autoinjector allowing the automatic delivering of a first dose of a medicament and the manual administration of a second dose. The autoinjector device according to this patent foresees the use of a syringe housed slidably in a tubular housing in two parts that can be separated to allow positioning of the syringe containing two doses of the medicament to be delivered and removal after use. The sliding of the syringe in the housing to penetrate the needle and inject the medicament is operated by an actuator movable between an armed position and an extended position. A releasable locking device is provided to limit the syringe plunger sliding to an extent corresponding to the volume of the first dose. The syringe is mounted in the tubular housing in a movable way to enable the locking device to be removed after the first dose is delivered and the plunger drive means to be armed again, if the second dose is to be automatically administered, or the syringe to be removed, if the second dose is to be manually administered. Furthermore the drive means is provided with a safety lock formed by a member engaging with a deformable pin of the drive means to keep it in a deformed condition, thereby preventing it to trigger. An autoinjector of this type is commercially available under the trade mark Twinject® and allows the first dose to be administered automatically, but the second dose must be manually administered.
The autoinjector according to EP651662 is designed to carry out a sequence of injections from a single syringe that is capable of performing a limited sliding movement in a tubular housing. The syringe has a plunger to deliver doses of a medicine through the needle and spring drive means engage with a plunger rod and, once they are armed, retain the rod in a first position, while, when they are triggered, cause the rod to move forward and this causes first the syringe sliding and needle projection and then a controlled sliding of the plunger to deliver a medicine dose. Manual arming means are provided and means to trigger again the spring drive means.
The plunger rod has a toothed profile on which a catch of the drive means engages and the syringe is housed in a bushing capable of moving in a limited way in the tubular housing and provided with a further catch that is also engaged with the toothed profile of the rod. When the device is armed by the manual arming means, both the drive means and the bushing in which the syringe is placed are displaced toward the rear end of the tubular housing, the two catches engaging with the toothed profile of the rod. An axial groove connection between the bushing and the drive means allows a further sliding between the catch integral to the drive means and the toothed profile of an extent equal to the pitch of the profile. When the device is triggered, first the drive means cause the syringe bushing to slide up to a front stop and then the rod start sliding relative to the bushing catch for an extent corresponding to the profile pitch, whereby the displacement of a volume of medicine is enabled together with its deliver through the needle.
There is a strong need for an injector device for the automatic injection of a medicament in two successive doses which is user-friendly and is easier to manufacture as compared to the conventional devices. The object of the present invention is therefore to meet these requirements by providing a medicament autoinjector device capable of enabling the patient to self-administering two successive doses of a medicament in the easiest possible way, thus sparing the patient of performing potentially dangerous, complex dismounting/re-arming operations.
The general object of the present invention is to provide a device for the automatic injection of multiple discrete nominal volumes of a drug compound, especially two doses of the drug compound from the same syringe.
A particular object of the present invention is to provide a device of the above mentioned type in which the automatic injection of discrete nominal volumes of drug compound is achieved by combination of rotational and translational movements of device components.
Another object of the present invention is to provide a device of the above mentioned type in which the automatic injection of a prescribed dose is triggered by use of a patient activated linear sliding of a component in combination with the angular displacement of plunger means being guided by cam means in an encapsulated chassis.
It is a further object of the present invention to provide a device of the above mentioned type with an automatic sheathing lock-out feature for needle protection and prevention of inadvertent triggering of the device before a dose is selected by the user.
Still another object of the present invention is to provide a device of the above mentioned type capable of automatic re-sheathing the needle and resetting the lock-out condition after a dose is injected.
Another object of the invention is to provide a device of the above mentioned type in which the triggering function and the driving function are integrated on same support to lower tolerances, increase reliability and reduce the number of components of the device, this also resulting in a simple device structure and production cost reduction.
Still another object of the invention is to provide an autoinjector device of the above mentioned type in which the production and assembling thereof are easy to carry out.
The above objects are achieved with the device for the automatic injection of doses of a medicament according to the present invention, whose main features are set forth in the attached claim 1. Further important features are set forth in the dependent claims.
According to an important aspect of the device for the automatic injection of doses of a drug compound according to the present invention, the axial movement of a sliding sheath, caused by the user by depressing its front end against the injection site, causes the angular displacement of cam trigger means, which, in cooperation with stepped guide means, controls the movement of plunger means of a syringe group and thus the delivery of prefixed doses of a drug compound. The movement of the plunger means is produced by axially operating first elastic means, while the axial movement of the sliding sheath is hindered by second elastic means that reinstate the initial needle covering condition of the sheath when the pressure action ceases. To make the device ready for the delivery of a dose, device arming means are provided which, when operated, unlock the sheath axial sliding. The lock-out condition, as well as the needle retraction in the sliding sheath, are automatically reinstated when the pressure ceases under the action of the second elastic means.
According to another important aspect of the invention, the cam trigger means are formed on the same support, axially pivotable, as cam drive means with which the sliding sheath interacts to control the triggering of the plunger means of the syringe group.
According to a further aspect of the invention the means allowing the device to be kept in a rest state are formed on the support of the cam trigger means and the cam drive means and are unlocked as a result of a rotation of a dose selection knob pivotally mounted on the device body and temporarily connected to the support.
The above and other features, as well as the advantages of the auto-injector device according to the invention will be apparent from the following description of an exemplifying, non-limiting embodiment thereof with reference to the attached drawings, in which:
a, 22b and 22c are detail views of the device of the invention in position 0 (stored position) and in the position 1 (first dose armed);
a and 23b show the device of the invention at the beginning and at the end of the first dose delivery step;
a and 25b show the details of the second dose s election step;
a, 26b and 26c show the steps of delivery of the second dose;
a is a detail sectional view of the connection between plunger rod and ratchet;
a, b and c are, respectively, side view, perspective view and longitudinal section view taken along lines 40c-40c of
a, b and c are, respectively, side view, perspective view and reversed perspective view of the cam sleeve in the device of
a and 43b are detail views of the device of
c is a transverse sectional view of the device in the first dose armed position of
a and 44b show the device immediately before and at the triggering point;
a and 46b show the device in the stored position after delivering the first dose and, respectively, in the second dose armed position and ready for delivering the second dose;
a, b and c are broken-up partial side perspective views showing the device of
a, b and c are detail side views of the bayonet connection of the device according to the second embodiment of the invention before, during and, respectively, at the decoupling step.
With reference to
A dose selection knob 4, on which a reference indicator 5 is formed, is provided at the rear end of the device. The dose selection knob 4 is axially pivotable relative to the outer body 1 to allow the indicator 5 to align to the reference marks 4 formed thereon.
A syringe group, generally indicated at 6, is housed in the outer body 1. As shown in
In the device stored state the dose selection knob 4 is connected to part 8b of the plunger rod 8 by a bayonet connection, shown in particular in
Two radial pegs 15 outwardly project from the part 8b of the plunger rod at diametrically opposed parts. The two radial pegs 15, which slide in trigger cam means, provide a means to guide the movement of the plunger rod 8 which controls the drug dose delivery, as will be explained later on.
As shown in
The dose selection knob 4 may rotate in only one direction and to this end the connection between the knob 4 and the outer body 1 comprises means for preventing the rotation in the direction opposite to that of dose selection. These means comprise a pair of ratchet legs 18 (see
As shown in
As shown in
The cam sleeve 23 is pivotable in the outer body 1 and is kept into axial alignment by the positioning flange 24.
The rear section 23b of the cam sleeve 23 is provided with trigger cam means to control the movements of the plunger rod 8. The trigger cam means comprise two windows 26 diametrically opposed and symmetrical to the axial rotation as regard their shape, opened toward the rear edge of the cam sleeve through a respective axially extending channel 27 defining a first dose trigger cam track 27a. Each window is delimited by two parallel circumferential sides 26a, 26b, by an axial side 26c linking two ends of the sides 26a, 26b, and by an inclined side 26d, opposed to the axial side 26c, linking the other end of the side 26b opposite to the channel 27 to one side of the channel 27. The channel 27 opens in the window 26 at the inclined side 26d and the axial side 26c forms the second dose trigger cam track. The first dose trigger cam track 26c is angularly spaced from the second dose trigger cam track 27a.
Drive cam means 28 are embossed on the outer surface of the front section 23a of the cam sleeve 23. The drive cam means 28 is formed by a cam profile repeated four times in an angularly equispaced fashion on said surface. The cam profile comprises a first drive cam track 28a, extending from the end of the sleeve cam 23, called upward track for sake of simplicity, and inclined with respect to the axis X, and a second drive cam track 28b, called downward track for sake of simplicity, extending from the same end of the cam sleeve 23 and incident with the first drive cam track 28a. On the upward track 28a and, successively, on the downward track 28b a pair of drive pins 32 is designed to slide. The drive pins 32 project inwardly from two diametrically opposed, axial drive legs 31 of the sliding sheath 30 (
In the downward track 28b of the drive cam means 28 relevant cantilever legs 29 are formed to be inwardly deflected to allow passage of the drive pins 32. In the stored state of the device the drive pins 32 abut on an axial lock-out edge 29a (
The end of the sliding sheath 30 at the side opposite to the drive legs 31 constitutes the front end 3 of the device, i.e. the end intended to be brought into contact with the patient skin at the injection site. The needle 7a of the syringe 7 will project from said front end 3 through a central aperture 33 thereon. A central spring boss 34 for slidably housing the syringe 7 extends from the inner face of the front end 3 of the sliding sheath 30. A return spring 35 is wound around the central spring boss 34 and abuts against the inner face of the front end 3 with one end and against a surface of the outer body 1 with its other end.
The drive legs 31 are slidingly engaged with axial guides 36 formed in the outer body 1, whereby the sliding sheath 30 may only move axially in the outer body 1. Two wide axial openings 37, arranged at 90° relative to drive legs 31, are formed on sliding sheath 30. The axial openings 37 are axially aligned to corresponding transparent inspection windows 38 formed on the outer body 1, through which the barrel 7c of the syringe 7 is visible, whereby the user can control the drug delivery condition. The abutment surface for the return spring 35 on the outer body 1 is constituted by the bottom wall 38a of said inspection windows 38. The axial openings 37 allow the sliding sheath 30 to travel axially by the required distance whilst not clashing with the windows in the outer body 1.
A pair of assembly clips 39 extends from the bottom of, and within the axial openings 37 of the sliding sheath 30 to snap engage with corresponding end stops 40 formed at the front end of the outer body 1, so as to allow the assembly of the sliding sheath 30 within the outer body 1 and prevent release thereof.
The front edge of the outer body 1 abuts on respective lead edges 41a of a pair of flexible tines 41 formed on the sliding sheath 30 at diametrically opposed sides. The lead edge 41a of these tines is inclined so as to provide resistance to the movement of the sliding sheath 30 and make this movement possible only as a result of a moderate thrust that deflects the tines 41 inwardly until the edge of the outer body 1 overcomes the most projecting end of the tines 41. The motion subsequently created by the release of the tines 41 helps to quickly insert the needle 7a of the syringe 7 into the injection site.
A tubular housing 42 for the syringe 7 is formed in the outer body 1 and a flange 42a is formed at one end thereof, on which a corresponding flange 7e of the barrel 7c rests. The two flanges are locked to each other by retention clips 43 inwardly projecting from the outer body 1 (see
As shown in
A needle shield remover 45 (
The following is a description of the way the auto-injector device according to the invention is used.
In the initial state, the stored state, the power spring 10 is compressed between the closed end of the part 8a of the plunger rod 8 and the bottom wall 4a of the dose selection knob 4. The bayonet connection between the knob 4 and the plunger rod 8 secures the power spring 10 in compression until the first dose is selected. Any buckling of the power spring 10 is prevented thanks to its being arranged between the radial ribs 9 and the part 8a of the plunger rod 8 at one side and the support rod 11 at the other one. The needle shield 7b is secured to the syringe 7 and the needle shield remover 45 secured to the needle shield 7b. The cap 2 is secured to the outer body 1 and the sliding sheath 30 is prevented from moving axially because the drive pins 32 of the of the drive legs 31 abut against the respective lock-out edges 29a of the cam sleeve 23.
The dose selection knob 4 is connected to the outer body 1 through its external perimetrical groove 16, with which slidingly engages the undercut 17 on the rear end of the outer body 1. Once assembled, the dose selection knob 4 cannot move axially, but can only rotate in one direction. The rotation direction is indicated by the reference marks on the outer body: in other words, indicator 5 starts from the position 0, rotates to the position 1 when the first dose is selected, and then rotates to the position 2 when the second dose is selected.
In the stored state the device is “locked-out”, i.e. the sliding sheath 30 cannot move in the outer body 1, because the drive legs 31 of the sliding sheath 30 abut against the axial lock-out edges 29a of the cam sleeve 23. This condition is shown in particular in
First the user must slide back and remove the end cap 2 in order to expose the needle shield remover 45. The end cap 2 will have to be replaced once the first dose is delivered when the device is not in use. The end cap 2 protects the drug from light exposure and prevent particulates from coming into contact with the front end 3 of the device.
To perform the first injection the user must remove the needle shield remover 45. In this way the needle shield 7b is also removed leaving the needle 7a uncovered, but still sub-flush of the front end 3 and not readily visible to the user. To unlock the device and select the delivery of the first dose, the user rotates the dose selection knob 4 from position 0 (stored state) to position 1 (first dose armed).
The rotation of the dose selection knob 4 from position 0 to position 1 causes the rotation of the cam sleeve 23, whereby the axial lock-out edges 29a of the cantilever legs 29 displace relative to the drive pins 32 of the legs 31 of the slidable sheath 30, which abut against the circumferential stop edge 28d to prevent the knob 4 to further rotate until the first dose is delivered and are aligned to the upward portions 28a of the cam track 28 free to move along them. The user recognizes the end of rotation to position 1 when he/she sees that the indicator 5 lines up with the position 1 marker, feels the increase in rotation resistance of the drive pins 32 contacting the cam track 28 and also hears the “click” as produced by the ratchet legs 18 falling off the step 19a of the ramp surface 19. The contrast between legs 18 and steps 19a prevent the knob 4 from rotating in the reverse direction.
The device is triggered by the user pressing the front end 3 of the sliding sheath 30 against the injection site by keeping the device through the outer body 1. The movement of the sliding sheath 30 in the outer body 1 finds a resistance due to the contrast between the flexible tines 41 and the end of the outer body 1. Due to their flexibility and the inclined contact surface, the flexible tines 41 depress and fully deflect inwardly to allow the passage of the sliding sheath 30 which can slide in the outer body 1 leaving the needle 7a to project from its front end 3, so that the needle can penetrate in the injection site. The motion subsequently created by the release of the flexible tines 41 helps to quickly insertion of the needle 7a in the injection site.
The axial movement of the sliding sheath 30 in the outer body 1 causes the rotation of the cam sleeve 23 and the latter would frictionally draw into rotation also the dose selection knob 4. To prevent the knob 4 from rotating during the step of first dose delivery, between the dose selection knob 4 and the outer body 1 temporary stop means are provided that mutually engage when the free ends of the ratchet legs 18 fall off the step 19a of the ramp surface 19 of the outer body 1. In the present embodiment the temporary stop means comprise retention pips 46 of the outer body engaging with corresponding catches 47 of the knob 4, as shown in
The rotation of the cam sleeve 23 causes the plunger rod 8 to rotate because of the engagement of its radial pegs 15 in the corresponding axial channels 27. After a few degrees of rotation the bayonet connection between the dose selection knob 4 and the plunger rod 8 decouples because the retention clips 13 of the knob 4 reach the relevant axial release slot branches 12b of the plunger rod 8 and, under the action of the power spring 10, the plunger rod 8 is pushed forward to bring the radial pegs 15 to lean on the first location face 44a of the stepped guide 44 of the outer body 1.
While the cam sleeve 23 keeps rotating, the radial pegs, pushed by the first dose trigger cam track 27a, slide on the first location face 44a until they reach the end thereof and fall off the second location face 44b of the stepped guide 44 under the action of the power spring 10. This sequence is shown in
After delivery of the first dose, the user removes the device from the injection site and the needle 7a withdraws therefrom. The return spring 35 is no longer hindered by the forced contact between the front end 3 and the injection site and thereby pushes the slidable sheath 30 axially forward thus resheathing the needle. At the same time the drive pins 32 of the drive legs 31 slide down in the downward portion 28b of the cam track 28 depressing inwardly the cantilever legs 29 until the device returns to a “lock-out” condition, wherein the drive pins 32 contact the free end 29a of the cantilever legs 29 and the assembly clips 39 of the sliding sheath 30 again engage with end stops 40 of the outer body 1, as shown in
If the delivery of a second dose is necessary, the user un-caps the device to enable access to the sliding sheath 30. To unlock the device the user must rotate the dose selection knob 4 from the position 1 (first dose armed position) to the position 2 (second dose armed position).
To that end the user must overcome the reaction of the catches 47 of the knob 4 on retention pips 46 of the outer body 1. The feet 21 of the knob 4 take up the free travel on seat 22 of the cam sleeve 23 until they reach the leading edge 22a to rotate the cam sleeve 23 to position 2, as shown in
The device is triggered for the delivery of the second dose by the user pressing the front end 3 of the sliding sheath 30 against the injection site by keeping the device through the outer body 1. The movement of the sliding sheath 30 in the outer body 1 finds a resistance due to the contrast between the flexible tines 41 and the end of the outer body 1. Due to their flexibility and the inclined contact surface, the flexible tines 41 depress and fully deflect inwardly to allow the passage of the sliding sheath 30 which can slide in the outer body 1 leaving the needle 7a to project from its front end 3, so that the needle can penetrate in the injection site. The motion subsequently created by the release of the flexible tines 41 helps to quickly insert the needle 7a in the injection site.
To prevent any further rotation of the knob 4, once the position 2 is reached, at the end of the following rotation of the cam sleeve 23 the base of the ratchet legs 18 contacts the stop rib 20 of the indexing ramp 19, by what the ratchet legs 19 are retained between the step 19a and said stop rib 20.
While the cam sleeve 23 keeps on rotating, the radial pegs 15 slide on the second location face 44b of the stepped guide 44 as pushed by the axial side 26c of the window 26 until they reach the end of said face, from which they fall off the stop ledge 44c of the stepped guide 44 due to the action of the power spring 10. This operating sequence is shown in
It is worth noting that a small drug volume always remains in the syringe barrel. In fact, the position of the stop ledge 44c of the stepped guide 44 is designed in the way that, when the radial pegs 15 reach the stop ledge 44c, the plunger stopper 7d does not touch the bottom of the barrel 7c. In this way, not only the delivery of the prescribed volume of drug is allowed to be controlled, but also any manufacturing variability with respect to the internal length of the syringe barrel is ensured to be mitigated. Therefore the dose accuracy is improved.
After delivery of the second dose, the user removes the device from the injection site and the needle 7a withdraws therefrom. The return spring 35 is no longer hindered by the forced contact between the front end 3 and the injection site and thereby pushes the slidable sheath 30 axially forward thus resheathing the needle. At the same time the drive pins 32 of the drive legs 31 slide down in the downward track 28b of the drive cam means 28 and depress inwardly the cantilever legs 29 until the device returns to a “lock-out” condition, wherein the drive pins 32 contact the free end 29a of the cantilever legs 29 and the assembly clips 39 of the sliding sheath 30 again engage with end stops 40 of the outer body 1, as at the end of the delivery of the first dose. The needle 7a is again not accessible as being covered by the sliding sheath 30. The user then recaps the device with its end cap 2 before disposal/handling to paramedic.
Even if the autoinjector device according to the invention described above is equipped with two radial pegs 15 to guide the movements of the plunger rod 8, this solution being the preferred one to have a symmetrical distribution of the forces acting on the various components, it is clear that the solution in which only one radial peg 15 is provided is comprised in the scope of the invention as being an obvious variation thereof. In this case, the stepped guide means 44, the trigger cam means 26, 27 and the drive cam means 28 will be modified consequently.
With reference to
In the proximity of the other end, the rear end, of the outer body 100 angularly spaced reference marks are formed or labelled, for example the numerals 0, 1, 2, indicating a rest or stored state (0), and two operating states (1, 2) of the device, as will be explained later on.
A dose selection knob 104, from which a reference indicator 105 axially extends, is provided at the rear end of the outer body 100. The dose selection knob 104 is axially pivotable relative to the outer body 100 to allow the indicator 105 to align to the reference marks formed thereon.
In the present embodiment of the invention a substantially cup-shaped ratchet 204 is housed underneath the dose selection knob 104. The ratchet 204 is made integral to knob 104 through a pair of wings 205 internally extending in the knob at diametrically opposite parts and formed with cuts 206 for snap fitting with side axial retention ribs 204c of the ratchet 204 (see
A syringe group, generally indicated at 106, is housed in the outer body 100. As shown in
The inner diameter of the plunger rod 108 is sized to house a power spring 110 axially extending all over its length. As shown in
From the bottom wall of the dose selection knob 104 there extend inwardly a pair of diametrically opposed bosses 109 (
The plunger rod 108 and the ratchet 204 are coupled by a bayonet connection that keeps the power spring in a compressed state until the device is triggered. With reference to
Two radial pegs 115 outwardly project from the rear part 108b of the plunger rod 108 at diametrically opposed parts. The two radial pegs 115, shown in particular in
The connection between the outer sleeve 100b and the knob-ratchet assembly is made (see
The dose selection knob 104 may rotate in only one direction relative to sleeve 100b and to this end the connection between the ratchet 204 and the sleeve 100b comprises means for preventing the rotation in the direction opposite to that of dose selection after the knob reaches one of the operating positions. These means comprise a pair of flexible ratchet legs 118 (see
As shown in
As shown in
The cam sleeve 123 is pivotable in the outer sleeve 100b and is kept into axial alignment by the positioning flange 124. The rotation stop end is made by a pair of side ribs 124a on the outer edge of flange 124 abutting on corresponding abutments, not shown, formed in the sleeve 100b.
The rear section 123b of the cam sleeve 123 is provided with trigger cam means to control the movements of the plunger rod 108. The trigger cam means comprise two windows 126 diametrically opposed and symmetrical to the axial rotation as regard their shape, opened toward the rear edge of the cam sleeve through a respective axially extending channel 127 defining a first dose trigger cam track 127a. Each window 126 is delimited by two parallel circumferential sides 126a and 126b, by an axial side 126c linking two ends of the sides 126a, 126b, and by an inclined side 126d, opposed to the axial side 126c, linking the other end of the side 126b, opposite to the channel 127, to one side of the channel 127. The channel 127 opens in the window 126 at the inclined side 126d and the axial side 126c forms the second dose trigger cam track. The first dose trigger cam track 127a is angularly spaced from the second dose trigger cam track 126c. In the present embodiment the side 126b is placed at the end of a widened gap in windows 126 to account for clearances and tolerances associated with manufacturing variation of component features.
Drive cam means 128 are embossed on the outer surface of the front section 123a of the cam sleeve 123. The drive cam means 128 is formed by a cam profile repeated four times in an angularly equispaced fashion on said surface. The cam profile comprises a first drive cam track 128a, extending from the end of the cam sleeve 123, called upward track for sake of simplicity, and inclined with respect to the axis X, and a second drive cam track 128b, called downward track for sake of simplicity, extending from the same end of the cam sleeve 123 and incident with the first drive cam track 128a. On the upward track 128a and, successively, on the downward track 128b a pair of drive pins 132 is designed to slidingly urge. The drive pins 132 project inwardly from two diametrically opposed, axial drive legs 131 of the sliding sheath 130 (
In the downward track 128b of the drive cam means 128 relevant cantilever legs 129 are formed to be inwardly deflected to allow passage of the drive pins 132 during the drive pin return stroke in the downward track. In the stored state of the device the drive pins 132 abut on an axial lock-out edge 129a at the free end of the cantilever legs 129, thereby preventing the sliding sheath 130 from moving toward the rear end of the device. A stop edge 128c, placed sideways of the axial lock-out edge 129a, serves as abutment for drive pins 132 to prevent the ratchet 204 from rotating beyond the positions of first dose and second dose delivery, as will be explained later on.
The end of the sliding sheath 130 at the side opposite to the drive legs 131 constitutes the front end 103 of the device, i.e. the end intended to be brought into contact with the patient skin at the injection site. The needle 107a of the syringe 107 will project from said front end 103 through a central aperture 133 thereon. A return spring 135 abuts with one end against the inner face of the front end 103 of the sliding sheath 130 and against pushing surface of chassis 100a with its other end. Sideways the return spring 135 is guided by alignment ribs 134 formed inside the sheath 130.
A pair of assembly clips 139 extends outwardly from the ends of the legs 131 to snap engage with axial guide slots 147 formed along the chassis 100a. The legs 131 deflect when the device is being assembled so as to allow the assembly clips 139 to engage in the slots 147 and the axial movement of the sliding sheath 130 while preventing release thereof.
Since the drive legs 131 are slidingly engaged with axial guide slots 147 formed in the chassis 100a, the sliding sheath 130 may only move axially in the outer body 100 along axial alignment tracks 136 inwardly projecting from the inner face of the chassis 100a. Two wide axial openings 137, arranged at 90° relative to drive legs 131, are formed on sliding sheath 130. The axial openings 137 are axially aligned to corresponding transparent inspection windows 138 formed on the chassis 100a, through which the barrel 107c of the syringe 107 is visible, whereby the user can control the drug delivery condition. The abutment surface for the return spring 135 on the chassis 100a is constituted by the bottom wall 138a of said inspection windows 138. The axial openings 137 allow the sliding sheath 130 to travel axially by the required distance whilst not clashing with the windows 138 of the chassis 100a.
Flexible tines 141 project from diametrically opposed parts of the sliding sheath 130 and have an active surface inclined so as to provide resistance to the movement of the sliding sheath 130 when it abuts against corresponding inner protrusions 141a at the front end of the axial alignment tracks 136 of the chassis 100a (see
A tubular housing 142 for the syringe 107 is formed in the chassis 100a and an inward edge 142a is formed at the front end thereof, on which the front end of the barrel 107c seats. At the other end of the tubular housing 142 the barrel 107c projects with a flange 107e, above which the front face of the cam sleeve 123 lies (see
As shown in
A needle shield remover 145 is removably secured to the sliding sheath 130 by snap engageable retention fingers 145a abutting against a flange at the front end of the sheath 130 and is provided with an inner tubular grip member 145b in which an insert 146 is arranged for engaging on the needle shield 107b through retention hooks (not shown) digging into the rubber needle shield, in such a way that, by pulling the needle shield remover 145 before the first dose is administered, the user can remove the needle shield 107b and free the needle 107a for the injection.
The operation of the auto-injector device according to the second embodiment of the invention is described here below. As already said, the operation is substantially equal to that of the previously described embodiment of the invention. Reference is made to
In the initial state, the stored state, the power spring 110 is compressed between the closed end of the part 108a of the plunger rod 108 and the bottom wall 204a of the ratchet 204 integral to the dose selection knob 104. The bayonet connection between the ratchet 204 and the plunger rod 108 secures the power spring 110 in compression until the first dose is triggered. Any buckling of the power spring 110 is prevented thanks to its being arranged between the part 108b of the plunger rod 108 and the support rod 111.
The needle shield 107b is secured to the syringe 107 and the needle shield remover 145 is secured to the needle shield 107b through the insert 146. The cap 102 is secured to the chassis 100a and the sliding sheath 130 is prevented from moving axially because the drive pins 132 of the drive legs 131 abut against the respective lock-out edges 129a of the cam sleeve 123.
The dose selection knob 104 is connected to the outer body 100 as the sleeve 100b is held captive between the knob 104 and the ratchet 204 integral to each other. Once assembled, the assembly formed by the dose selection knob 104 and the ratchet 204 cannot move axially, but can only rotate in one direction. The rotation direction is indicated by the reference marks on the outer body 100: in other words, indicator 105 starts from the position 0, rotates to the position 1 when the first dose is selected, and then rotates to the position 2 when the second dose is selected.
In the stored state the device is “locked-out”, i.e. the sliding sheath 130 cannot move in the outer body 100, because the drive legs 131 of the sliding sheath 130 abut against the axial lock-out edges 129a of the cam sleeve 123. This condition is shown in particular in
It must be pointed out that, as shown in
First the user must slide back and remove the end cap 102 in order to expose the needle shield remover 145. The end cap 102 will have to be replaced once the first dose is delivered when the device is not in use. The end cap 102 protects the drug from light exposure and prevents particulates from coming into contact with the front end 103 of the device.
To perform the first injection the user must remove the needle shield remover 145. In this way the insert 146 and the needle shield 107b are also removed leaving the needle 107a uncovered, but still sub-flush of the front end 103 and not readily visible to the user. To unlock the device and select the delivery of the first dose, the user rotates the dose selection knob 104 from position 0 (stored state) to position 1 (first dose armed).
The rotation of the dose selection knob 104 from position 0 to position 1 causes the rotation of the cam sleeve 123, whereby the axial lock-out edges 129a of the cantilever legs 129 displace relative to the drive pins 132 of the legs 131 of the slidable sheath 130, which abut against the stop edge 128c to prevent the knob 104 to further rotate until the first dose is delivered and are aligned to the upward portions 128a of the cam track 128 free to move along them (see
The device is triggered by the user pressing the front end 103 of the sliding sheath 130 against the injection site by keeping the device through the outer body 100. The movement of the sliding sheath 130 in the outer body 100 finds a resistance due to the contrast between the flexible tines 141 of the sliding sheath 130 and the inner protrusions 141a of the chassis 100a. Due to their flexibility and the inclined contact surface, the flexible tines 141 depress and fully deflect inwardly while overcoming the protrusions 141a to allow the passage of the sliding sheath 130 which can slide in the chassis 100a leaving the needle 107a to project from its front end 103, so that the needle can penetrate in the injection site. The motion subsequently created by the release of the flexible tines 141 helps to quickly insert the needle 107a in the injection site
The axial movement of the sliding sheath 130 in the outer body 100 causes the rotation of the cam sleeve 123 and the latter would frictionally draw into rotation also the ratchet 204 and the dose selection knob 104. To prevent the knob 104 from rotating during the step of first dose delivery, between the ratchet 204 and the sleeve 100b temporary stop means are provided that mutually engage when the free ends of the ratchet legs 118 fall off the ribs 119 of the sleeve 100b. In the present embodiment the temporary stop means comprise the stop ribs 120 of the sleeve 100b abutting on the corresponding protrusions 120a of the ratchet 204, as shown in
The rotation of the cam sleeve 123 causes the plunger rod 108 to rotate because of its radial pegs 115, engaged in the corresponding axial channels 127 are pushed by the trigger cam track 127a. The angular displacement of the plunger rod 108 causes the bayonet connection to decouple as the actuation slots 113 of the plunger rod 108 slide on the respective retention feet 112 of the ratchet 204 until the slots 113 get free of the feet 112. This sequence is shown in
After delivery of the first dose, the user removes the device from the injection site and the needle 107a withdraws therefrom. The return spring 135 is no longer hindered by the forced contact between the front end 103 and the injection site and thereby pushes the slidable sheath 130 axially forward thus resheathing the needle. At the same time the drive pins 132 of the drive legs 131 slide down in the downward portion 128b of the cam track 128 depressing inwardly the cantilever legs 129 until the device returns to a “lock-out” condition, wherein the drive pins 132 contact the free end 129a of the cantilever legs 129 and the assembly clips 139 of the sliding sheath 130 again engage with end stops 140a in the axial guides 136 of the chassis 100a, as shown in
The needle 107a is again not accessible as being covered by the sliding sheath 130, which, in this state, is prevented from sliding until the user rotates the dose selection knob 104 to position 2. The user then recaps the device. The end cap 102 snap fits with outer body 100 to securely hold on the chassis 100a.
If the delivery of a second dose is necessary, the user un-caps the device to enable access to the sliding sheath 130. To unlock the device the user must rotate the dose selection knob 104 from the position 1 (first dose armed position) to the position 2 (second dose armed position) (see
To that end the user must overcome the reaction of the stop ribs 120 of the sleeve 100b on the protrusions 120a of the ratchet 204. Deflection of protrusions 120a allows the knob 104 to rotate. The feet 121 of the ratchet 204 take up the free travel on grooves 122 of the cam sleeve 123 until the turning legs 121a reach the leading edges 122a to rotate the cam sleeve 123 to position 2, as shown in
The rotation of the cam sleeve 123 causes the device to unlock because the drive pins 132 of the drive legs 131 of the sliding sheath 130 line up the upward portion 128a of the cam track 128 while contacting the stop edge 128c to prevent a further rotation of the knob 104 once the position 2 is reached. The reverse rotation of the dose selection knob 104 is prevented by the ratchet legs 118 snap abutting on the protrusions 119 of the sleeve 100b. The rotation of the cam sleeve 123 also causes the repositioning of the radial pegs 115 from the outlet of the axial channel 127 within the window 126 to the opposite axial side 126c, while their position on the location face 144a of the stepped guide 144 is unchanged (
The device is triggered for the delivery of the second dose by the user pressing the front end 103 of the sliding sheath 130 against the injection site by keeping the device through the outer body 100. The movement of the sliding sheath 130 in the chassis 100a caused by the drive pins 132 of the legs 131 pushing against the upward track 128a finds a resistance due to the contrast between the flexible tines 141 of the sliding sheath 130 and the inner protrusions 141a of the chassis 100a. Due to their flexibility and the inclined contact surface, the flexible tines 141 depress and fully deflect inwardly overcoming the protrusions 141a to allow the passage of the sliding sheath 130 which can slide in the chassis 100a leaving the needle 107a to project from the front end 103, so that the needle can penetrate in the injection site. The motion subsequently created by the release of the flexible tines 141 helps to quickly insert the needle 107a into the injection site. The thrust produced by the drive pins 132 does not cause any significant axial movement of the cam sleeve 123, because its positioning flange 124 axially abuts against the rim 125 of the sleeve 100b.
To prevent any further rotation of the knob 104, once the position 2 is reached, at the end of the following rotation of the cam sleeve 123 the free end of the ratchet legs 118 abut on the stop ribs 119 thus preventing the reverse rotation of the knob 104, whereas the forward rotation is hindered by the contrast between the stop rib 120 of the sleeve 100b and the protrusion 120a of the ratchet 204 (
While the cam sleeve 123 keeps on rotating, the radial pegs 115 slide on the location face 144a of the stepped guide 144 as pushed by the axial side 126c of the window 126 until they reach the end of said face, from which they fall off the stop ledge 144c of the stepped guide 144 due to the action of the power spring 110. This operating sequence is shown in
After delivery of the second dose, the user removes the device from the injection site and the needle 107a withdraws therefrom. The return spring 135 is no longer hindered by the forced contact between the front end 103 and the injection site and thereby pushes the slidable sheath 130 axially forward thus resheathing the needle. At the same time the drive pins 132 of the drive legs 131 slide down in the downward track 128b of the drive cam means 128 and depress inwardly the cantilever legs 129 until the device returns to a “lock-out” condition, wherein the drive pins 132 contact the free end 129a of the cantilever legs 129 and the assembly clips 139 of the sliding sheath 130 again engage with end stops 140a in the axial guides 136 of the chassis 100a, as at the end of the delivery of the first dose. The needle 107a is again not accessible as being covered by the sliding sheath 130. The user then recaps the device with its end cap 102 before disposal/handling to paramedic.
The autoinjector device according to the invention is suitable to the delivery of medicaments in solution, especially epinephrine (also known as adrenaline).
In particular, the doses of epinephrine that can be administered with the device of the invention are preferably in the range of 0.05 mg to 0.5 mg for each delivered dose (from 0.1 mg to 1 mg if two doses are considered).
Preferred doses for each delivery are 0.05 mg, 0.10 mg, 0.15 mg, 0.30 mg and 0.50 mg.
The above doses are based on a concentration of the epinephrine solution preferably ranging from 0.05 mg/ml to 0.5 mg/ml, the concentrations 0.05 mg/ml, 0.1 mg/ml, 0.16 mg/ml, 0.3 mg/ml and 0.5 mg/ml being particularly preferred.
Number | Date | Country | Kind |
---|---|---|---|
FI 2011 A 000194 | Sep 2011 | IT | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP2012/067438 | 9/6/2012 | WO | 00 | 3/4/2014 |